Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel gastrointestinal agents in early development at Dainippon

March 12, 1998

New cisapride formulation introduced in U.K.

March 9, 1998

Astra develops new gastric antisecretory agents

March 6, 1998

Triangle Pharmaceuticals obtains license to L-FMAU for HBV treatment

March 5, 1998

NIH will license technology that may lead to new HCV vaccines

March 3, 1998

Profile of a motilide: Abbott's ABT-229

March 2, 1998

First approvals for Zadaxin outside Asia

March 2, 1998

Priority review status granted for Avakine

Feb. 26, 1998

Cell adhesion inhibitors from Yoshitomi

Feb. 26, 1998

Abbott reveals new motilides

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...